EDOC Acquisition Corp. Announces Voting Results of Extraordinary General Meeting to Approve the Extension Amendment
15 Août 2022 - 3:16PM
EDOC Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC” or the
“Company”), a special purpose acquisition company, announced today
that the Company’s shareholders voted in favor of the proposal to
amend its charter (the “Extension Amendment”) to extend the date by
which the Company has to complete a business combination from
August 12, 2022 to February 12, 2023 (the “Extension”), at the
extraordinary general meeting of EDOC shareholders that took place
August 12, 2022 at 8:00 pm ET. The Extension Amendment was approved
by a vote of approximately 99% of the ordinary shares voted, which
represented approximately 68.1% of the outstanding ordinary shares.
A Current Report on Form 8-K disclosing the full voting results
will be filed with the Securities and Exchange Commission.
About EDOC Acquisition
Corp.
EDOC Acquisition Corp. is a blank check company
organized for the purpose of effecting a merger, share exchange,
asset acquisition, share purchase, recapitalization,
reorganization, or other similar business combination with one or
more businesses or entities. The company is sponsored by an
extensive network of physician entrepreneurs across 30+ medical
specialties in leading medical institutions and is led by Kevin
Chen, Chief Executive Officer of EDOC.
Contact:
EDOC Acquisition Corp. 7612 Main Street Fishers Suite 200
Victor, NY 14564 Attention: Kevin Chenkevin.chen@edocmed.net
Edoc Acquisition (NASDAQ:ADOCW)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Edoc Acquisition (NASDAQ:ADOCW)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024